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Background: Frailty describes the aging-associated loss of physiological and psycholog-
ical reserves, leading to an increased risk of adverse health outcomes. Many developed
countries view frailty as a major priority for their health and social care systems. Less
is known about frailty in less-developed countries. The purpose of this study was to
determine the prevalence of frailty in a sample of community-dwelling older people in
the United Arab Emirates (UAE).
Methods: This was a cross-sectional study of community-dwelling Emirati adults aged
55 years and older (n=160) in Abu Dhabi, UAE. Data were collected at interview by
questionnaire and physical measurements. Frailty was defined according to the criteria
of the Fried Frailty Index. The prevalence of frailty and its association with selected
independent variables were assessed.
Results: The overall prevalence of frailty (95%CI) was 47% (39–55). Higher levels of frailty
were seen in older age groups, women, those who were non-married, those with recent
hospital admission, those with comorbid conditions, those on more than five medications,
and those with lower forced expiratory volume and mini-mental state examination score.
After adjustment in a multiple logistic regression model, only age and gender were found
to be independently associated with frailty.
Conclusion: A high prevalence of frailty was found among older Emiratis. Given that
frailty is associated with adverse health outcomes and can be a means of identifying
opportunities for intervention in clinical practice and health policy, further attention and
consideration within professional and public health policy circles are needed.
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INTRODUCTION
Not everyone can “age well,” persons with the same chronological age may vary according to health
and functional status. Although there is no single accepted definition, “frailty” is used to describe
the multidimensional syndrome in which there is a loss of physiological and psychological reserves
leading to increased vulnerability to adverse health outcomes, such as falls, loss of mobility and
independence, hospitalization, and death (1).
Frailty is important for both clinicians and health service managers because it identifies groups
of people who need different types of intervention and higher levels of health and social care (2, 3).
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It is generally accepted that the prevalence of frailty increases
with age and is higher in women and those with chronic disease.
However, estimates vary due to the different definitions of frailty
that are in use.
In epidemiological studies, frailty is operationalized in two
main ways. First, as a frailty phenotype such as the Fried Frailty
Index (FFI) based on the presence of three or more of five compo-
nents (unintentional weight loss, self-reported exhaustion, weak-
ness, slow walking speed, and low physical activity) (4). Second,
using a definition that includes psychosocial attributes such as the
frailty index (FI), which is based on routine clinical assessment
and lists deficits in selected areas such as mood, cognition, and
continence (5, 6).
Many variations of these definitions can be found in the litera-
ture along with descriptions of the instruments that will measure
them. Most definitions also allow for an intermediate pre-frailty
state. The different definitions of frailty result in the reporting of
a wide range of frailty prevalence between studies.
Population aging is occurring throughout the world and cur-
rently persons aged 60 or over account for 12% of the global
population while those aged 80+ account for 1.7% (7). The cor-
responding percentages in a highly developed country such as
Germany are 27.6 and 5.7%.
Faced with an aging population and an increasing number of
frail elderly persons, many developed countries now view frailty
as a major priority for their health and social care systems. This
has resulted in a growth in frailty research including efforts to
accurately estimate the prevalence of frailty using well-designed
epidemiological surveys (8).
For example, a review that pooled the results of 21 studies
found that amongover 60,000 community-dwelling older persons,
the average prevalence of frailty was 10.7% and a further 41.6%
were pre-frail (9). Amongst the studies, which were conducted in
Europe, US, Canada, Australia, and Taiwan, rates varied greatly
from 4 to 60%. A physical definition of frailty, either the FFI or a
modification, was the most commonly used definition of frailty,
and in studies using this definition, average prevalence was 10%
compared to 13.6% in studies using a broader definition. Among
women, the prevalence of frailty and pre-frailty was 9.6 and
39%, respectively, while among men it was 5.2 and 37%. Frailty
increased with age, the prevalence in those aged 65–69 was 4%, in
those aged 70–74 it was 7%, in those aged 75–79 it was 9%, in those
aged 80–84 it was 16%, and in those aged 85 and over it was 26%.
The population of the United Arab Emirates (UAE) enjoys a
high level of health as measured by life expectancy (76.7 years),
under-fivemortality (7.2 per 1000 live births), and infantmortality
(6.2 per 1000 live births) although levels of chronic disease risk
factors are high and there is significant health loss from cardio-
vascular disease and diabetes (10). The age and sex structure of
the UAE population is unusual as it is dominated by expatriate
men and women of working age (11). This means that while the
median age of the population is 33.3, only 2.3% are aged 60+ and
0.1% are aged 80+. However, rapid aging can be expected, so that
by 2050, it is estimated that 23.5% of the population will be aged
60+ and 4.1% will be aged 80+.
Given the relationship between age and frailty and frailty and
healthcare outcomes, these figures highlight the challenges that
the UAE health and social care systems must address in the not-
too-distant future. Population-based data on the scale of frailty
amongst UAE elders are lacking. Also, the relationship between
frailty and ethnicity, nationality, and culture has not been widely
researched (12). Frailty may be more prevalent among UAE citi-
zens as a result of the high burden of diabetes and cardiovascular
disease (13). On the other hand, strong family networks may
protect against the effects of frailty on health outcomes. Therefore,
the objectives of this study were to determine the prevalence
and correlates of frailty in a sample of community-dwelling older
Emiratis.
MATERIALS AND METHODS
A cross-sectional study of Emirati adults aged 55 years and older
was conducted in the emirate of Abu Dhabi, UAE, between
September andDecember 2014.Obtaining probability samples for
population research in UAE is challenging (14) for a number of
reasons not least being the lack of suitable sampling frames, so in
this study participants were recruited from among community-
dwelling older people living in different areas of the UAE who
visited the primary healthcare facilities at ZayedMilitaryHospital,
Abu Dhabi. It was acknowledged that this would give higher
estimates of frailty prevalence. The targeted sample size was 160,
based on an assumed true frailty prevalence of 30% and an accept-
able precision of 7%. Persons aged 0–54, non-UAE nationals
and non-Arabic speakers, were excluded. To minimize inter-rater
variation, all interviews and measurements were performed by a
single researcher (Saleha JaberAl-Kuwaiti). This studywas carried
out in accordance with the recommendations of the Research
Ethics Committee of Zayed Military Hospital. All participants
received information and provided informed written consent in
accordance with the Declaration of Helsinki.
Data Collection
An interviewer-administered questionnaire, in Arabic, obtained
information on age, gender, and marital status. Respondents
were asked whether they lived alone and if they had experienced
unintentional weight loss, exhaustion, or slow walking speed.
Respondents were then asked about comorbidities, regular use of
medication, recent hospitalization, use of vitamin D supplements,
and how they rated their general health and overall memory.
Measurements
Grip strength was measured in the right hand using an ana-
log hand dynamometer with participants seated, elbow by their
side and flexed to right angle, and a neutral wrist position. The
dynamometer handle position was adjusted to fit the subject’s
hand, and the average of threemeasurements of peak grip strength
was recorded. A standard “timed up and go test (TUG)” was car-
ried out. Subjects rose from an armchair andwalked 3m at normal
pace, with usual footwear and walking aid as necessary, before
returning to the chair and resuming the sitting position. The time
in seconds taken to accomplish this exercise was recorded. Forced
expiratory volume (FEV) was measured as a potential correlate
of frailty using a standard clinic Vitalograph© (15). Mental state
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was assessed using a modification of the mini-mental state exam-
ination (MMSE) (16). Some items were excluded from theMMSE
test to make it more applicable to the subjects in this study, these
included spelling, reading, and drawing. Subjects were assessed
and scored for orientation, memory, attention, and calculation.
The total possible score for the modified instrument was 26.
Definitions
Five components made up the frailty phenotype used in this
study. These are mostly retained from those proposed by Fried
although changes were required to meet the particular needs of
the study population. Unintentional weight loss was categorized
as self-reported weight loss of 4.5 kg or more in the previ-
ous year. Self-reported exhaustion was defined as an affirma-
tive response to the question “in the last month have you felt
fatigue/exhaustion/tiredness or weakness.” Slow walking speed
was also self-reported. Muscle weakness was defined as having
hand-grip strength less than the lower 95% confidence interval
for age group and gender taken from a table of normative data
obtained in accordance with the American Society of Hand Ther-
apists recommendations in multinational settings (17). Low phys-
ical activity was defined as having a TUG time greater than 12 s,
which approximates the upper 95% confidence interval from nor-
mative data collected on a sample of community-dwelling elderly
people with independent functioning (18). Frailty was defined as
the presence of three or more frailty components while pre-frailty
was defined as the presence of two or more components.
Statistical Analysis
All data were normally distributed except mini-mental status
examination, even after log transformation. In the univariate anal-
ysis, categorical variables are presented as frequencies and per-
centages and continuous variables are presented as means SD.
The distribution of the characteristics of the study population
for each frailty state is tabulated. For characteristics that are cat-
egorical variables, frequencies and percentages are shown and
the significance of any differences in distribution is assessed by
using chi-square and Fisher’s exact tests. For characteristics that
are continuous variables, means are shown and one-way ANOVA
tests are used. Univariate binary logistic regression analysis was
performed to assess the association between frailty (outcome
variable) and selected correlates (independent variables). Finally,
the variables having P-values <0.2 were included in a multiple
logistic regression model and a stepwise backward elimination
method was adopted to adjust for confounders and identify the
independent factors associated with frailty. Microsoft Excel 2010©
was used for data entry and analyses were conducted using Stata
(version 13). Statistical significance was defined as P-values<0.05
and 95% confidence intervals.
RESULTS
The mean age of the study participants (n= 160) was 65 years
and 56% (n= 90) were male. The characteristics of the study
participants are summarized in Table 1. The majority of par-
ticipants were married (83%) and few (15%) lived alone. Frailty
characteristics were generally widespread among participants,
TABLE 1 | Characteristics of community-dwelling older Emirati citizens
(n=160a) attending primary healthcare services, Abu Dhabi, 2014.
Variable Descriptive statistics
SOCIODEMOGRAPHIC CHARACTERISTICS
Age in years (meanSD) 65.66.2
Age group, n (%)
55–59 years 22 (13.8)
60–64 years 54 (33.8)
65–69 years 41 (25.6)
70–74 years 25 (15.6)
75 years 18 (11.2)
Gender, n (%)
Male 90 (56.3)
Female 70 (43.7)
Marital status, n (%)
Married 133 (83.1)
Unmarried/divorced/widow(er) 27 (16.9)
Live alone, n (%)
Yes 24 (15.0)
No 136 (85.0)
FRAILTY INDICATORS
Unintentional weight loss, n (%)
Yes 33 (20.6)
No 127 (79.4)
Self-reported exhaustion, n (%)
Yes 107 (67.0)
No 53 (33.0)
Slow walking speed, n (%)
Yes 109 (68.5)
No 50 (31.5)
Grip strengthb (kg, meanSD) 42.714.5
Timed up and go testc (s, meanSD) 15.26.5
FRAILTY CORRELATES
Comorbid conditions, n (%)
Yes 136 (85.5)
No 23 (14.5)
Use of more than five medications, n (%)
Yes 65 (40.6)
No 95 (59.4)
Number of admissions to hospital in past 1 year, n (%)
No admission 123 (76.9)
1 admissions 37 (23.1)
Use of vitamin D supplement, n (%)
Yes 94 (58.7)
No 66 (41.3)
Self-reported health status, n (%)
Excellent 7 (4.4)
Good 123 (76.9)
Poor 30 (18.8)
Self-reported memory status, n (%)
Excellent 17 (10.6)
Good 120 (75.0)
Poor 23 (14.4)
Forced expiratory volume (ml, meanSD) 223.679.9
MMSE (score range, 0–26) (meanSD) 21.54.2
aTotal do not always sum to n=160 because of missing values.
bGrip strength cutoffs (kilograms) are as follows: age 55–59: male=36.7, female=26.4;
age 60–64: male=36.8, female=22.2; age 65–69: male=35.4, female=22.5;
age 70–74: male=32, female=20.7; age 75+: male=12.7, female=16.0.
cTimed up and go test cutoff=12 s.
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TABLE 2 | Frailty status according to the characteristics of the subjects and unadjusted odds ratio of frailty in community-dwelling older Emirati citizens
(n=160) attending primary healthcare services, Abu Dhabi, 2014.
Variables N Frailty Odds ratioa 95% CI P-valuec
Frail Pre-frail Not frail P-valueb
Overall frailty, n (%) (95% CI) 151 75 (46.9)
(39.2–55.2)
53 (33.1)
(25.9–40.9)
23 (14.4)
(9.1–20.3)
Age in years (meanSD) 160 68.35.6 62.44.4 60.62.4 <0.001 1.31 1.20–1.43 <0.001
Age in categories, n (%)
55–59 years 22 3 (13.6) 12 (54.5) 7 (31.8) <0.001
60–64 years 53 17 (32.1) 22 (41.5) 14 (26.4)
65–69 years 40 21 (52.5) 17 (42.5) 2 (5.0)
70–74 years 24 23 (95.8) 1 (4.2) 0 (0.0)
75 years 12 11 (91.7) 1 (8.3) 0 (0.0)
Gender, n (%)
Male 86 31 (36.0) 37 (43.0) 18 (20.9) <0.001 1
Female 65 44 (67.7) 16 (24.6) 5 (7.7) 3.71 1.88–7.35 <0.001
Marital status, n (%)
Married 127 58 (45.7) 46 (36.2) 23 (18.1) 0.018 1
Unmarried/divorced/widow(er) 24 17 (70.8) 7 (29.2) 0 (0.0) 2.89 1.12–7.45 0.028
Live alone, n (%)
Yes 23 12 (52.2) 10 (43.5) 1 (4.3) 0.294 1.13 0.46–2.74 0.794
No 128 63 (49.2) 43 (33.6) 22 (17.2)
Comorbid conditions, n (%)
Yes 128 72 (56.3) 43 (33.6) 13 (10.2) <0.001 1
No 22 2 (9.1) 10 (45.5) 10 (45.5) 12.86 2.88–57.33 0.001
Use of more than five medications, n (%)
Yes 59 42 (71.2) 17 (28.8) 0 (0.0) <0.001 1
No 92 33 (35.9) 36 (39.1) 23 (25.0) 4.42 2.18–8.95 <0.001
Number of admissions to hospital in past 1 year, n (%)
1 Admissions 32 21 (65.6) 11 (34.4) 0 (0.0) 0.008 1
No admission 119 54 (45.4) 42 (35.3) 23 (19.3) 2.30 1.02–5.19 0.045
Use of vitamin D supplement, n (%)
Yes 90 48 (53.3) 27 (30.0) 15 (16.7) 0.280 1.44 0.75–2.77 0.275
No 61 27 (44.3) 26 (42.6) 8 (13.1) 1
Self-reported health status, n (%)
Excellent/good 122 56 (45.9) 45 (36.9) 21 (17.2) 0.161 0.45 0.19–1.03 0.061
Poor 29 19 (65.5) 8 (27.6) 2 (6.9) 1
Self-reported memory status, n (%)
Excellent 17 6 (35.3) 5 (29.4) 6 (35.3) 0.022
Good 114 55 (48.2) 42 (36.8) 17 (14.9) 1
Poor 20 14 (70.0) 6 (30.0) 0 (0.0) 2.68 0.97–7.40 0.057
Forced expiratory volume (meanSD) 160 188.149.1 262.180.5 280.787.1 <0.001 0.17 0.09–0.31 <0.001
MMSE score (meanSD) 160 19.73.8 23.72.6 24.71.5 <0.001 0.64 0.56–0.74 <0.001
n, frequency; CI, confidence interval.
aFor the purpose of calculating the odds ratio, frailty was defined as the presence of three or more components of the frailty phenotype. For the continuous independent variables, the
OR shown is the increase or decrease in odds of frailty per unit change in the variable as follows: age=1 year, FEV=1 SD, and MMSE=one point change in score.
bChi-square test or Fisher’s exact test was used for categorical variables and one-way ANOVA was used for continuous variables.
cThese P-values refer to univariate binary logistic regression analysis.
with 20% reporting unintentional weight loss, 67% reporting
exhaustion, and 68% reporting slow walking speed while mean
grip strength was 42.7 kg and mean TUG time was 15.2 s. Most
participants (85%) admitted to having comorbid conditions, 23%
had been admitted to hospital at least once during the previous
year, 40% were taking more than five medications, and 58% were
taking vitamin D supplements. Eighty-one percent of participants
described their health status as excellent or good, whereas 19%
said it was poor. Similar replies were obtained when participants
were asked about memory status. Two possible correlates of frailty
were measured, mean FEV was 223ml and the mean score on the
modified MMSE was 21.5 (maximum possible score 26).
Among this sample of community-dwelling older Emirati citi-
zens attending primary healthcare services, frailty was common.
The prevalence of frailty (95% CI) was 47% (39–55) and the
prevalence of pre-frailty was 33% (26–41). Higher levels of frailty
were seen in the older age groups, amongwomen and among those
whowere unmarried, divorced, orwidowed. Frailty prevalence did
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TABLE 3 | Multiple logistic regression analysis and adjusted odds of
frailty and independent variables among community-dwelling older Emirati
citizens (n = 160) attending primary healthcare services, Abu Dhabi, 2014.
Variables Frailty-adjusted
odds ratio
95% CI P-value
Age 1.28 1.11–1.46 <0.001
Gender
Male 1
Female 3.23 1.02–10.24 0.046
Number of hospital admissions
No admission 1
1 admissions 3.34 0.92–11.99 0.065
Comorbid condition
No 1
Yes 4.40 0.66–28.57 0.122
Health status
Poor 1
Good/excellent 0.31 0.08–1.30 0.110
Forced expiratory volume 0.45 0.22–1.00 0.052
Mini-mental status examination score 0.87 0.72–1.05 0.157
n= frequency; CI= confidence interval.
Only associations with P< 0.2 are reported.
not vary by living status. Frailty was more common in those with
comorbid conditions, those using more than five medications,
those admitted to hospital within the previous year, and those
reporting poor memory. The prevalence of frailty did not vary
with vitamin D supplementation or self-reported health status.
Frailty was associated with lower MMSE score and lower FEV.
Table 2 summarizes these findings.
The association between frailty as an outcome variable and
selected population characteristics as independent variables is
also summarized in Table 2. For the purpose of this analysis,
only frailty (as defined by the presence of three or more frailty
components) is used. The positive association of frailty with older
age, female gender, non-married status, the presence of comor-
bid conditions, hospital admission, and use of more than five
medications and the negative association of frailty with FEV and
MMSE score are confirmed. After adjustment in the multivariate
model, only age and gender retained their association with frailty
(Table 3).
DISCUSSION
We found a high prevalence (47%) of frailty in our sample of
community-dwelling older Emirati citizens attending primary
healthcare services. To the best of our knowledge, no population-
based data are available from previous studies investigating frailty
in the UAE. The prevalence of frailty in our study was higher than
that seen in many other studies. However, comparison of frailty
levels in our sample with those found in other populations and
settings is problematic for two main reasons. First, although we
used the five components of the FFI to define frailty, these can be
operationalized in different ways, so that studies are not compa-
rable even when they purport to use the FFI. Second, we studied
a convenience sample of community-dwelling older Emirati citi-
zens attending primary healthcare services rather than a random
sample of the general elderly population. It is to be expected that
our sample would have higher levels of frailty notwithstanding
any environmental, ethnic, or cultural differences. That said, in
a large representative sample of older people in the United States,
among those in residential care the prevalence of frailty was 30%
and among those with an overnight hospitalization in the previous
12months it was 42% (19).
As reported in previous studies, we confirmed higher levels of
frailty at older ages and among women (20).We did not find inde-
pendent associations between frailty and comorbid conditions,
hospital admission, and being non-married although such asso-
ciations have been reported before. Also, we did not show associ-
ations with some other frailty correlates that have been reported
in other studies, for example, cognitive function as measured by
theMMSE (21) and FEV1. A high proportion of participants were
taking vitamin D supplements which may not be unanticipated
given that vitamin D deficiency is widely publicized in the UAE
and has been shown to be associated with frailty in older men
(22), but we did not show an independent association between
frailty and supplementation or other medication use. Our study
had modest power which may explain these failures also much
of our data are based on self-reports and frail participants may
have poor recollection that they have been started on vitamin
supplementation.
We did not collect data on educational attainment, income,
or ethnicity, factors that have been shown to be associated with
frailty, because these would not have been relevant or appropriate
questions for elderly Emiratis. Also we have not been able to
comment on whether frail participants in our study experienced
an increased risk of adverse outcomes or whether cultural and
environmental factors maymitigate against such outcomes. These
may be topics for future studies.
Our findings must be interpreted in light of the acknowledged
limitations of this study. The non-random and selective nature of
the sample limits generalizability to the wider general population
of elderly Emiratis and prevents thorough comparison with other
studies. The modest sample size widens the confidence intervals
on the estimates of prevalence and reduces the power of the
study to show small associations between frailty and potential
explanatory variables. Our findings are based on cross-sectional
data, and so the direction of relationships between frailty and
potential correlates cannot be determined. Information on three
of the five components of frailty was obtained by self-reports, and
this carries the inevitable concern about the overall validity of the
FFI as a measure of frailty and a predictor of health outcomes.
Finally, as might be expected in an elderly population, there was
correlation between some of the independent variables notably
age and FEV and MMSE score. Although the fitted regression
models did not show signs of multicollinearity, we cannot be
certain that the estimated coefficients are unaffected.
CONCLUSION
For the first time, using the five components of the FFI, we have
reported a high prevalence of frailty among older Emiratis. Given
that frailty is associated with adverse health outcomes and can be
a means of identifying opportunities for intervention in clinical
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practice and health policy, the high prevalence that we have found
merits further attention and consideration within professional
and public health policy circles. We would propose a UAE action
plan comprising a program of frailty research including longi-
tudinal studies combined with the development of best practice
guidelines for use in clinical and social care settings.
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